HIV coinfection with tuberculosis overview: Difference between revisions

Jump to navigation Jump to search
m (Changes made per Mahshid's request)
 
(One intermediate revision by the same user not shown)
Line 4: Line 4:


==Overview==
==Overview==
HIV is the main reason for failure to meet Tuberculosis (TB) control targets in high HIV settings. In spite of fewer people in USA suffering with TB, it remains a serious threat, especially for HIV-infected persons. In fact, worldwide TB is one of the leading causes of death among people infected with HIV. It is estimated that about 4.2% of Americans, with or without HIV infection, are infected with TB bacteria. People infected with HIV are more likely than uninfected people to get sick with other infections and diseases.
[[Human Immunodeficiency Virus (HIV)|HIV]] is considered a main cause of inability to control [[tuberculosis]] (TB) in high [[Human Immunodeficiency Virus (HIV)|HIV]] settings. In spite of fewer people in USA suffering with [[Tuberculosis|TB]], it remains a serious threat, especially for [[Human Immunodeficiency Virus (HIV)|HIV]]-infected persons. In general, [[Tuberculosis|TB]] is one of the leading causes of death among [[Human Immunodeficiency Virus (HIV)|HIV]]-infected patients. It is estimated that about 4.2% of Americans, with or without HIV infection, are infected with [[Tuberculosis|TB]] bacteria.


[[Immune reconstitution inflammatory syndrome ‎|IRIS]] is a group of clinical syndromes associated with immune reconstitution that have been observed most commonly for mycobacterial infections (TB and disseminated MAC disease).<ref name="pmid11784229">{{cite journal |author=Navas E, Martín-Dávila P, Moreno L, Pintado V, Casado JL, Fortún J, Pérez-Elías MJ, Gomez-Mampaso E, Moreno S |title=Paradoxical reactions of tuberculosis in patients with the acquired immunodeficiency syndrome who are treated with highly active antiretroviral therapy |journal=Arch. Intern. Med. |volume=162 |issue=1 |pages=97–9 |year=2002 |month=January |pmid=11784229 |doi= |url=http://archinte.ama-assn.org/cgi/pmidlookup?view=long&pmid=11784229 |accessdate=2012-04-06}}</ref>
[[Immune reconstitution inflammatory syndrome ‎|IRIS]] refers to a group of clinical [[Syndrome|syndromes]] associated with [[Immune reconstitution inflammatory syndrome|immune reconstitution]] which have been commonly linked to [[Mycobacterium|mycobacterial]] infections (TB and disseminated MAC disease).<ref name="pmid11784229">{{cite journal |author=Navas E, Martín-Dávila P, Moreno L, Pintado V, Casado JL, Fortún J, Pérez-Elías MJ, Gomez-Mampaso E, Moreno S |title=Paradoxical reactions of tuberculosis in patients with the acquired immunodeficiency syndrome who are treated with highly active antiretroviral therapy |journal=Arch. Intern. Med. |volume=162 |issue=1 |pages=97–9 |year=2002 |month=January |pmid=11784229 |doi= |url=http://archinte.ama-assn.org/cgi/pmidlookup?view=long&pmid=11784229 |accessdate=2012-04-06}}</ref>


Tuberculosis infection in HIV patients also affect the initiation of treatment. <ref name="pmid9164318">{{cite journal |author=Jacobson MA, Zegans M, Pavan PR, O'Donnell JJ, Sattler F, Rao N, Owens S, Pollard R |title=Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy |journal=Lancet |volume=349 |issue=9063 |pages=1443–5 |year=1997 |month=May |pmid=9164318|doi=10.1016/S0140-6736(96)11431-8 |url=http://linkinghub.elsevier.com/retrieve/pii/S0140-6736(96)11431-8|accessdate=2012-04-06}}</ref>
Tuberculosis infection in [[Human Immunodeficiency Virus (HIV)|HIV]] patients also affect the initiation of [[treatment]]. <ref name="pmid9164318">{{cite journal |author=Jacobson MA, Zegans M, Pavan PR, O'Donnell JJ, Sattler F, Rao N, Owens S, Pollard R |title=Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy |journal=Lancet |volume=349 |issue=9063 |pages=1443–5 |year=1997 |month=May |pmid=9164318|doi=10.1016/S0140-6736(96)11431-8 |url=http://linkinghub.elsevier.com/retrieve/pii/S0140-6736(96)11431-8|accessdate=2012-04-06}}</ref>


==Pathophysiology==
==Pathophysiology==
People infected with HIV (the virus that causes AIDS) are more likely than uninfected people to get sick with other infections and diseases. Tuberculosis (TB) is one of these diseases. TB is a disease that usually affects the lungs. It sometimes affects other parts of the body, such as the brain, the kidneys, or the spine.
The likelihood of getting sick with other [[Infection|infections]] and [[Disease|diseases]] is much more in [[Human Immunodeficiency Virus (HIV)|HIV]]-infected individuals. [[Tuberculosis]] ([[Tuberculosis|TB]]) is one of these diseases. [[Tuberculosis|TB]] commonly affects the [[Lung|lungs]]; however, It can sometimes affects other organs and body parts, such as the [[brain]], [[heart]], [[Kidney|kidneys]], or [[Spinal cord|spine]].


==Medical Therapy==
==Medical Therapy==
Recommendations for treating tuberculosis in adults with HIV infection are, with a few exceptions, the same as those for adult TB patients who are not HIV infected. However, managing HIV-related TB is complex and people with HIV and TB should seek care from a health care provider or providers with expertise in the management of both HIV disease and TB. Because persons with HIV infection are often taking numerous medications, some of which interact with anti-TB medications, experts in the treatment of HIV-related TB should be consulted.
There are no differences between [[tuberculosis]] treatment in [[Human Immunodeficiency Virus (HIV)|HIV]]-infected adults and adults [[Tuberculosis|TB]] patients without [[Human Immunodeficiency Virus (HIV)|HIV]] infection. However, [[Tuberculosis|TB]] management in [[Human Immunodeficiency Virus (HIV)|HIV]]-infected patients is complex and patients with both [[Human Immunodeficiency Virus (HIV)|HIV]] and [[Tuberculosis|TB]] infections have to seek the medical care from a health care provider or providers with experience in the management of both [[Human Immunodeficiency Virus (HIV)|HIV]] disease and [[Tuberculosis|TB]]. Because patients with [[Human Immunodeficiency Virus (HIV)|HIV]] infection are often taking several drugs, some of which interact with [[anti-TB drugs]], experts in the treatment of HIV-related TB should be consulted.


==Prevention==
==Prevention==
A new epidemiological model, developed by WHO, UNAIDS and the Stop TB Partnership, shows it is possible to reduce HIV/AIDS deaths impressively through tuberculosis (TB) prevention and treatment. In 2009 almost one in four deaths among people living with HIV were due to TB, a disease that is both curable and preventable. The model estimates that through the scaled-up implementation of WHO-recommended collaborative TB/HIV activities, it is possible to save a million lives by the end of 2015.
A new epidemiological model, developed by [[World Health Organization|WHO]], UNAIDS and the Stop [[Tuberculosis|TB]] Partnership, has reported that [[HIV AIDS|HIV/AIDS]] deaths can be reduced obviously through [[tuberculosis]] (TB) [[Prevention (medical)|prevention]] and [[treatment]]. In 2009, almost one in four deaths among [[Human Immunodeficiency Virus (HIV)|HIV]]-infected  patients were as a result of [[Tuberculosis|TB]], which is both curable and preventable nowadays.


==References==
==References==

Latest revision as of 05:07, 25 March 2021

HIV coinfection with tuberculosis Microchapters

Home

Patient Information

Overview

Pathophysiology

Causes

Differentiating HIV coinfection with tuberculosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Prevention

Case Studies

Case #1

HIV coinfection with tuberculosis overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of HIV coinfection with tuberculosis overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on HIV coinfection with tuberculosis overview

CDC on HIV coinfection with tuberculosis overview

HIV coinfection with tuberculosis overview in the news

Blogs on HIV coinfection with tuberculosis overview

Directions to Hospitals Treating HIV coinfection with tuberculosis

Risk calculators and risk factors for HIV coinfection with tuberculosis overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

HIV is considered a main cause of inability to control tuberculosis (TB) in high HIV settings. In spite of fewer people in USA suffering with TB, it remains a serious threat, especially for HIV-infected persons. In general, TB is one of the leading causes of death among HIV-infected patients. It is estimated that about 4.2% of Americans, with or without HIV infection, are infected with TB bacteria.

IRIS refers to a group of clinical syndromes associated with immune reconstitution which have been commonly linked to mycobacterial infections (TB and disseminated MAC disease).[1]

Tuberculosis infection in HIV patients also affect the initiation of treatment. [2]

Pathophysiology

The likelihood of getting sick with other infections and diseases is much more in HIV-infected individuals. Tuberculosis (TB) is one of these diseases. TB commonly affects the lungs; however, It can sometimes affects other organs and body parts, such as the brain, heart, kidneys, or spine.

Medical Therapy

There are no differences between tuberculosis treatment in HIV-infected adults and adults TB patients without HIV infection. However, TB management in HIV-infected patients is complex and patients with both HIV and TB infections have to seek the medical care from a health care provider or providers with experience in the management of both HIV disease and TB. Because patients with HIV infection are often taking several drugs, some of which interact with anti-TB drugs, experts in the treatment of HIV-related TB should be consulted.

Prevention

A new epidemiological model, developed by WHO, UNAIDS and the Stop TB Partnership, has reported that HIV/AIDS deaths can be reduced obviously through tuberculosis (TB) prevention and treatment. In 2009, almost one in four deaths among HIV-infected patients were as a result of TB, which is both curable and preventable nowadays.

References

  1. Navas E, Martín-Dávila P, Moreno L, Pintado V, Casado JL, Fortún J, Pérez-Elías MJ, Gomez-Mampaso E, Moreno S (2002). "Paradoxical reactions of tuberculosis in patients with the acquired immunodeficiency syndrome who are treated with highly active antiretroviral therapy". Arch. Intern. Med. 162 (1): 97–9. PMID 11784229. Retrieved 2012-04-06. Unknown parameter |month= ignored (help)
  2. Jacobson MA, Zegans M, Pavan PR, O'Donnell JJ, Sattler F, Rao N, Owens S, Pollard R (1997). "Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy". Lancet. 349 (9063): 1443–5. doi:10.1016/S0140-6736(96)11431-8. PMID 9164318. Retrieved 2012-04-06. Unknown parameter |month= ignored (help)

Template:WH Template:WS